R&D

Research and Development Activities

Developing a unique portfolio of differentiated, hard-to-be-manufactured and adding-value products is an integral part of our future growth strategy.

Our Strengths

Our research efforts are directed toward achieving our business vision of becoming a leading pharmaceutical company and steering to fill gaps in the market by developing high quality drugs. We also aim to respond to our patients unmet needs by adding value to the existing products in the market to provide improved therapeutic entities with more convenience, adherence, efficiency, safety and sustainability for patients.

As MS Pharma, we have more than 20-years of experience in formulation development, analytical development and conducting stability studies across different dosage forms including complicated ones.

Company Culture
  • Developing generic products and pharmaceutical formulations
  • Identifying niche areas (such as Cardiovascular diseases, Diabetes, and Neuroscience), for product development
  • Focusing on differentiated product technology including modified release formulations and other non-conventional dosage forms
  • Manufacturing of pilot stability batches.
  • Provides all analytical methods required for analysis of the finished products.
  • Developing generic products and pharmaceutical formulations
  • Identifying niche areas (such as Cardiovascular diseases, Diabetes, and Neuroscience), for product development
  • Focusing on differentiated product technology including modified release formulations and other non-conventional dosage forms
  • Manufacturing of pilot stability batches.
  • Provides all analytical methods required for analysis of the finished products.
  • Developing generic products and pharmaceutical formulations
  • Identifying niche areas (such as Cardiovascular diseases, Diabetes, and Neuroscience), for product development
  • Focusing on differentiated product technology including modified release formulations and other non-conventional dosage forms
  • Manufacturing of pilot stability batches.
  • Provides all analytical methods required for analysis of the finished products.

Research and Development Key

MS Pharma operates two R&D centers, located at both UPM and MS Pharma Injectables plant. R&D is centrally managed from MS Pharma and is focusing on differentiated product technology including modified release formulations, Injectables and other non-conventional dosage forms.

Our center is active across all facets of the Pharmaceutical Research and Development activities, which includes:

Product Portfolio

Why choose us?

As MSPharma , we have a more than 20-year of experience in Formulation Development, Analytical development and Conducting Stability Studies with more than 60 people committed to develop a range of formulation and products as per customer specifications and for positively impacting health and well-being.

Become a Partner

R&D Capability:

Our lines of R&D focus include:

Solid, liquid and semi-solid dosage forms:

Including tablets, hard gelatin capsules, soft gelatin capsules, pellets, oral solutions, dry suspensions, creams, ointments, gels and suppositories, In addition to liquid vials and infusion bags.

Lyophilization (Freeze drying) technology:

We are developing many products using this type of technology. Freeze-drying increases the shelf life of the products, such as vaccines and other injectables. By removing the water from the material and sealing the material in a vial, the material can be easily stored, shipped, and later reconstituted to its original form for injection.

Prefilled syringes:

It is a unique new project that will be ready during this year. Prefilled syringes are recognized as an efficient, reliable and convenient method for drug administration. Furthermore, the ease at which patient can self-administer many types of injectables drugs make prefilled syringes healthcare treatment possible out of hospital and into home.